GLYCODESIGN
GlycoDesign is a biopharmaceutical company, engages in the discovery and development of proprietary drugs for the treatment or prevention of cardiovascular and chronic inflammatory diseases, as well as cancer. It focuses on two anti-thrombotic drug candidates, GH9001 and ATH, as well as in the development of glycotherapeutics for the potential treatment of chronic inflammation and cancer.
GLYCODESIGN
Industry:
Biotechnology Pharmaceutical
Founded:
1993-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.glycodesign.com
Total Employee:
11+
Status:
Closed
Contact:
(416) 593-6027
Similar Organizations
Proacta Therapeutics
Proacta Therapeutics is a biopharmaceutical company, engages in the discovery and development of oncology drugs.
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 1999-11-08 | Vascular Therapeutics | Vascular Therapeutics acquired by GlycoDesign | N/A |
Official Site Inspections
http://www.glycodesign.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
